• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-14

  Oh and colleagues developed a scalable human sensory-neuron platform from inducible pluripotent stem cells and validated it against molecular, virological, and chromatin criteria for HSV-1 latency. The model supports controlled reactivation experiments and provides a human-relevant complement to animal systems for studying latent infection mechanisms.

• FXR–KLF11 Signaling in Contrast-Induced Kidney Injury

  2026-08-13

  The reference study identifies an FXR–KLF11 transcriptional axis that protects against contrast-induced acute kidney injury by suppressing JAK2/STAT3-driven inflammation and apoptosis. Using mouse and HK-2 cell models, the authors connect CDCA-dependent nuclear receptor activation with direct KLF11 promoter regulation, providing a mechanistic basis for further preclinical research rather than clinical proof.

• Z-YVAD-FMK Workflow for Caspase-1 Studies

  2026-08-13

  Use Z-YVAD-FMK to separate caspase-1-dependent pyroptosis and inflammatory signaling from caspase-3-associated apoptosis. This workflow combines solvent handling, dose selection, orthogonal readouts, and species-aware interpretation for inflammasome, infection, and cancer research.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-12

  FITC-Concanavalin A (ConA) Conjugate, SKU K4413, is a fluorescent lectin probe for visualizing accessible α-D-glucose and α-D-mannose moieties on glycoproteins and glycolipids. It is suited to cell surface carbohydrate detection, immunofluorescence staining, and flow cytometry, but not to identifying a specific glycoprotein or analyzing non-carbohydrate targets.

• Palomid 529 (P529) in Assay Design

  2026-08-12

  This scenario-based guide shows how Palomid 529 (P529), SKU A8618, can be incorporated into viability, proliferation, angiogenesis, and pathway-dependence experiments. It emphasizes solvent control, dose interpretation, storage, and vendor-selection criteria grounded in the product dossier and recent PI3K-AKT research.

• JZL184 and the CB1–GLT-1 Axis in TBI

  2026-08-11

  JZL184 offers a precise way to interrogate how MAGL-dependent 2-AG turnover shapes CB1 signaling, astrocytic GLT-1 expression, excitotoxicity, and cognitive outcomes after traumatic brain injury. This thought-leadership perspective translates recent mechanistic findings into an experimental strategy while clarifying what JZL184 can—and cannot—establish in translational neurobiology.

• BX795: PDK1 Inhibitor for Kinase and Immune Studies

  2026-08-11

  BX795 is an ATP-competitive PDK1 inhibitor with additional TBK1 and IKKε activity. Its profile supports mechanistic studies of PI3K/Akt/mTOR signaling, cancer cell growth inhibition, and innate immune response modulation, but cellular effects should not be assigned to PDK1 alone.

• Shufeng Xingbi Therapy in Allergic Rhinitis Rats

  2026-08-10

  This preprint examines how Shufeng Xingbi Therapy affects allergic rhinitis in rats by integrating nasal inflammation, Th1/Th2-associated signaling, intestinal microbiota, and serum short-chain fatty acids. Its main contribution is a multilevel association between treatment-related symptom improvement, microbiome shifts, increased SCFAs, and reduced allergic and nasal molecular markers, while its preclinical design limits causal and clinical interpretation.

• BODIPY 581/591 C11 in Ferroptosis Assays

  2026-08-09

  BODIPY 581/591 C11 is a ratiometric fluorescent probe for resolving membrane lipid peroxidation in endothelial ferroptosis studies. This article connects its spectral biology to the SOCE/O-GlcNAcylation findings reported in diabetic osteoporosis and explains how to avoid overinterpreting oxidative stress signals.

• Hexetidine (NSC-17764) Assay Guide

  2026-08-08

  A scenario-driven laboratory guide to using Hexetidine (NSC-17764), SKU BA1327, in antimicrobial, biofilm, and cell-compatibility workflows. It explains concentration selection, solvent controls, MIC interpretation, assay limitations, and practical vendor-selection criteria using product data and published evidence.

• Mapping SLC2A5 in CNS Lymphoma Tissue

  2026-08-07

  Single-cell evidence positions SLC2A5-mediated fructose metabolism as a potential vulnerability in primary CNS lymphoma. This thought-leadership guide translates that finding into practical, mechanism-aware tissue assay strategies using a Primary Antibody Dilution Buffer while distinguishing research evidence from workflow recommendations.

• Sulfaphenazole: Precision CYP2C9 Inhibitor for Vascular Rese

  2026-08-07

  Sulfaphenazole stands out as a selective CYP2C9 inhibitor, enabling robust workflows in vascular endothelial function and drug metabolism studies. Its well-characterized inhibition profile, low cytotoxicity, and translational impact are showcased by recent data-driven applications in diabetic vascular dysfunction and tissue injury models.

• PPP1R3G/PP1γ-Mediated RIPK1 Dephosphorylation Drives Cell De

  2026-08-06

  This study uncovers how PPP1R3G recruits PP1γ to dephosphorylate and activate RIPK1, thereby promoting apoptosis and necroptosis. The findings clarify a key regulatory checkpoint in inflammation and cell death, with implications for the targeted modulation of the NF-κB pathway in disease models.

• NADH in Mitochondrial Electron Transport Chain Research

  2026-08-06

  NADH (reduced nicotinamide adenine dinucleotide) empowers advanced mitochondrial electron transport chain research, disease modeling, and next-generation photocatalytic cancer therapy. This guide translates recent breakthroughs and reference-backed protocols into actionable workflows, troubleshooting insights, and practical innovations for high-fidelity metabolic assays.

• SlSLAH1-Mediated Malate Exudation Confers Aluminium Toleranc

  2026-08-05

  This study defines a molecular pathway in tomato where the anion channel SlSLAH1, regulated by the SlSTOP1-SlSZP1 transcriptional complex, drives malate exudation to mitigate aluminium toxicity. The findings clarify key regulatory components underlying aluminium tolerance and open new avenues for crop improvement.

17011 records 1/1135 page Next 12345 下5页 Last page